ALYGLO
Commercial- Indications
- Primary Humoral Immunodeficiency
Company intelligence / Profile preview
KabaFusion operates a nationwide network of accredited home infusion pharmacies and ambulatory suites. It specializes in the delivery of intravenous/subcutaneous immunoglobulin therapies as well as a broad range of acute and chronic infusion treatments. The company has demonstrated strong growth through acquisitions, including recent expansion into new states with the acquisition of Coram’s assets. Clinical outcomes are supported by dedicated nursing staff and pharmacist oversight. No clinical trial data reported; services are commercial standard-of-care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on KabaFusion.